Perioperative IDH inhibition in treatment-naive IDH-mutant glioma: a pilot trial.

Saved in:
Bibliographic Details
Title: Perioperative IDH inhibition in treatment-naive IDH-mutant glioma: a pilot trial.
Authors: Drummond KJ; Department of Neurosurgery, Royal Melbourne Hospital, Melbourne, Victoria, Australia. kate.drummond@mh.org.au.; Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia. kate.drummond@mh.org.au., Spiteri M; Personalised Oncology Division, WEHI, Melbourne, Victoria, Australia., Cain SA; Department of Neurosurgery, Royal Melbourne Hospital, Melbourne, Victoria, Australia., Jones J; Department of Neurosurgery, Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia., Shaya S; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Topp M; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Lu T; Personalised Oncology Division, WEHI, Melbourne, Victoria, Australia., Tobler R; Personalised Oncology Division, WEHI, Melbourne, Victoria, Australia., Valkovic AL; Personalised Oncology Division, WEHI, Melbourne, Victoria, Australia., Moore Z; Personalised Oncology Division, WEHI, Melbourne, Victoria, Australia.; Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia., Fatunla OE; Personalised Oncology Division, WEHI, Melbourne, Victoria, Australia.; Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia., Kriel J; Personalised Oncology Division, WEHI, Melbourne, Victoria, Australia.; Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia., Moffet JJD; Personalised Oncology Division, WEHI, Melbourne, Victoria, Australia.; Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia., McAlpine H; Department of Neurosurgery, Royal Melbourne Hospital, Melbourne, Victoria, Australia.; The Florey Institute of Neuroscience and Mental Health, The Florey Department of Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria, Australia., Rosier M; The Florey Institute of Neuroscience and Mental Health, The Florey Department of Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria, Australia., Guan H; The Florey Institute of Neuroscience and Mental Health, The Florey Department of Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria, Australia., Dimou J; Department of Neurosurgery, Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia., Schadewaldt V; Department of Neurosurgery, Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia., Roberts-Thomson S; Department of Anatomical Pathology, Royal Melbourne Hospital, Melbourne, Victoria, Australia., McArdle D; Department of Medical Imaging, Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Department of Radiology, University of Melbourne, Melbourne, Victoria, Australia., Lui E; Department of Medical Imaging, Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Department of Radiology, University of Melbourne, Melbourne, Victoria, Australia., Voelker-Albert M; MoleQlar Analytics GmbH, Munich, Germany., di Sanzo S; MoleQlar Analytics GmbH, Munich, Germany., Nijagal B; Metabolomics Australia, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, Victoria, Australia., Narayana VK; Metabolomics Australia, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, Victoria, Australia., Mitchell CB; Department Clinical Pathology, MDHS, University of Melbourne, Melbourne, Victoria, Australia.; Collaborative Centre for Genomic Cancer Medicine, MDHS, University of Melbourne, Melbourne, Victoria, Australia., Vissers JHA; Department Clinical Pathology, MDHS, University of Melbourne, Melbourne, Victoria, Australia.; Collaborative Centre for Genomic Cancer Medicine, MDHS, University of Melbourne, Melbourne, Victoria, Australia., Grimmond S; Collaborative Centre for Genomic Cancer Medicine, MDHS, University of Melbourne, Melbourne, Victoria, Australia., Rosenthal MA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Palmer LM; The Florey Institute of Neuroscience and Mental Health, The Florey Department of Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria, Australia., Best SA; Personalised Oncology Division, WEHI, Melbourne, Victoria, Australia.; Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia., Freytag S; Personalised Oncology Division, WEHI, Melbourne, Victoria, Australia.; Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia., Whittle JR; Personalised Oncology Division, WEHI, Melbourne, Victoria, Australia. whittle.j@wehi.edu.au.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. whittle.j@wehi.edu.au.; Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia. whittle.j@wehi.edu.au.
Source: Nature medicine [Nat Med] 2025 Oct; Vol. 31 (10), pp. 3451-3463. Date of Electronic Publication: 2025 Aug 21.
Publication Type: Clinical Trial, Phase I; Journal Article
Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1546-170X
DOI:10.1038/s41591-025-03884-4